Skip to main content
Market intelligence
SOPHSector not reported

SOPHiA Genetics SA insider activity

In the last 90 days, 1 corporate insider purchased $99,000 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$99,000
Corporate buyers
1
Latest transaction
Jun 25, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 25, 2026Abhimanyu VermaChief Technology OfficerSale6,944$5.51$38,229
Jun 25, 2026Philippe MenuChief Medical OfficerSale5,000$5.50$27,525
Jun 22, 2026George CardozaChief Financial OfficerSale774$5.38$4,164